Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Artificial Intelligence approach helps to identify patients with heart failure that respond to beta-blocker treatment Researchers at the University of Birmingham have developed a new way to identify which patients with heart failure will benefit from treatment with beta-blockers.
News New research to find out what damage diabetes does to the smallest blood vessels of the heart in order to develop new therapies
Posted 31 August 2021 Artificial Intelligence approach helps to identify patients with heart failure that respond to beta-blocker treatment Researchers at the University of Birmingham have developed a new way to identify which patients with heart failure will benefit from treatment with beta-blockers.
Posted 25 August 2021 Birmingham scientists discover new piece of clotting puzzle In research that provides a new perspective on how blood clotting works in infectious and inflammatory diseases, Birmingham scientists have described a potential new target and strategy for anti-thrombotic therapy.
Posted 04 August 2021 New research to find out what damage diabetes does to the smallest blood vessels of the heart in order to develop new therapies Dr Neena Kalia, Reader at the Institute of Cardiovascular Sciences, has been awarded a three-year BHF research grant to find out what damage diabetes does to the smallest blood vessels of the heart.
Posted 04 August 2021 New Birmingham-Roche collaboration targets new treatments for inflammatory bowel disease A new £850k collaboration between Birmingham Health Partners and global biotechnology leaders Roche is set to improve both diagnosis and care of patients with inflammatory bowel disease.